title: Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma.
abstract: OBJECTIVE
  To correlate aqueous humor soluble CD44 (sCD44) concentration, visual field loss, and glaucoma risk factors in primary open-angle glaucoma (POAG) patients.
  
  
  METHODS
  Aqueous samples were obtained by paracentesis from normal and glaucoma patients who were undergoing elective surgery and analyzed for sCD44 concentration by enzyme-linked immunosorbent assay.
  
  
  RESULTS
  In normal aqueous (n=124) the sCD44 concentration was 5.88+/-0.27 ng/mL, whereas in POAG aqueous (n=90) the sCD44 concentration was 12.76+/-0.66 ng/mL, a 2.2-fold increase (P<0.000001). In POAG patients with prior successful filtration surgery (n=13), the sCD44 concentration was decreased by 43% to 7.32+/-1.44 (P=0.001) in comparison with POAG patients without filtration surgery; however, the sCD44 concentration in the prior successful filtration subgroup with no medications and normal intraocular pressure was 12.62+/-3.81 (P=0.05) compared with normal. The sCD44 concentration of normal pressure glaucoma patients was 9.19+/-1.75 ng/mL, a 1.6-fold increase compared with normal (P=0.02). Race and intraocular pressure pulse amplitude were significant POAG risk factors in this cohort of patients. In both normal and POAG patients with mild and moderate visual field loss, sCD44 concentration was greater in African Americans than in whites (P=0.04).
  
  
  CONCLUSIONS
  sCD44 concentration in the aqueous of POAG patients correlated with the severity of visual field loss in all stages in white patients and in mild to moderate stages in African American patients. sCD44 concentration in aqueous is a possible protein biomarker of visual field loss in POAG.
authors: Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, USA.
authors: Michael J
authors: MJ
authors: Nolan
authors: Michael C
authors: MC
authors: Giovingo
authors: Adam M
authors: AM
authors: Miller
authors: Robert D
authors: RD
authors: Wertz
authors: Robert
authors: R
authors: Ritch
authors: Jeffrey M
authors: JM
authors: Liebmann
authors: R Rand
authors: RR
authors: Allingham
authors: Leon W
authors: LW
authors: Herndon
authors: Martin B
authors: MB
authors: Wax
authors: Regina
authors: R
authors: Smolyak
authors: Fareed
authors: F
authors: Hasan
authors: Edward M
authors: EM
authors: Barnett
authors: John R
authors: JR
authors: Samples
authors: Paul A
authors: PA
authors: Knepper
mesh_terms: D000328:Adult; D001741:Black or African American / Q000208:ethnology; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001082:Aqueous Humor / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism*; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy / Q000208:ethnology / Q000378:metabolism*; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism*; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012995:Solubility; D014786:Vision Disorders / Q000188:drug therapy / Q000208:ethnology / Q000378:metabolism*; D014794:Visual Fields; D044465:White People / Q000208:ethnology
chemical_list: D000959:Antihypertensive Agents; D015415:Biomarkers; C497483:CD44 protein, human; D018960:Hyaluronan Receptors